APA引文

Kabeshova, A., Ben Hariz, S., Tsakeu, E., Benamouzig, R., & Launois, R. (2016). Cost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France. Therap Adv Gastroenterol.

Citação norma Chicago

Kabeshova, Anastasiia, Soumaia Ben Hariz, Elyonore Tsakeu, Robert Benamouzig, and Robert Launois. "Cost-effectiveness Analysis of Rifaximin-α Administration for the Reduction of Episodes of Overt Hepatic Encephalopathy in Recurrence Compared With Standard Treatment in France." Therap Adv Gastroenterol 2016.

MLA引文

Kabeshova, Anastasiia, et al. "Cost-effectiveness Analysis of Rifaximin-α Administration for the Reduction of Episodes of Overt Hepatic Encephalopathy in Recurrence Compared With Standard Treatment in France." Therap Adv Gastroenterol 2016.